Oligomerix

0 followers


Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for Alzheimer’s disease and related dementias by targeting tau self-association. The company’s drug discovery platform has identified a pipeline of novel small molecule inhibitors, with preclinical I... Read more

Industries

Headquarters

Stage

Employees

Links

Org chart

James Moe
President and CEO, Co-Founder, Director, Principal Investigator

James Moe

Collapse
Eliot J. Davidowitz
Chief Scientific Officer, Co-Founder, and Director
Jack Pasini
Director, Chief Commercial Officer
Robert Foerster
Chief Financial Officer
William Erhardt
Chief Medical Officer